Pharmafile Logo
Pharmafocus logo
Advanced Search

ADHD

Showing 7 posts of 37 posts found.

Shire image

Shire posts strong quarter results

August 2, 2012
Sales and Marketing ADHD, Adderall XR, Pfizer, Q2, Shire, results

Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …

News
Shire image

Generic approval for Shire’s hyperactivity drug

June 26, 2012
Sales and Marketing ADHD, Adderall XR, FDA, IMS Health, Impax, Shire, Teva

US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …

News

Shire sales rocket with 25% growth

July 29, 2011
Sales and Marketing ADHD, Fabry disease, Gaucher's disease, Shire

Specialist pharma company Shire has posted exceptionally strong results for the second quarter, increasing its product sales by 30% and …

News

Shire thrives on specialist portfolio

February 11, 2011
Sales and Marketing 2010 pharma results, ADHD, Shire, Vyvanse

Speciality pharma company Shire has posted sales growth of 16%, led by its ADHD treatment Vyvanse. Sales of Vyvanse rose …

News
Blog footer

Digital Pharma: Janssen gets animated about ADHD

June 14, 2010
Medical Communications, Sales and Marketing ADHD, Janssen, disease awareness campaigns

Janssen-Cilag has launched a new UK campaign to raise awareness of ADHD among teenagers, their parents and teachers. The campaign’s …

News

AstraZeneca’s AZD3480 progresses in ADHD

July 11, 2009
Sales and Marketing ADHD, Alzheimer's, Alzheimer's ADHD, AstraZeneca

 AstraZeneca is to progress its AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million …

News

Shire acquires ADHD presence in Europe

February 23, 2009
Sales and Marketing ADHD, Shire

Shire has bought the global rights for two established treatments for Attention Deficit Hyperactivity Disorder from UCB. The acquisition gives …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025